Editor's note - Page 14 of 20 - Express Pharma

India Pharma Inc’s tryst with destiny continues

A wake up call for serialisation laggards

Racing against the GST deadline

Dull Q4FY17 could be a blessing in disguise

Towards sustainability

Bridging the skills gap

Passing the buck?

Does IP build or block?

US-India relationship: Can it trump the odds?

Collaborate to conquer